Analysing the ethics of breast cancer overdiagnosis: a pathogenic vulnerability

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Breast cancer screening aims to help women by early identification and treatment of cancers that might otherwise be life-threatening. However, breast cancer screening also leads to the detection of some cancers that, if left undetected and untreated, would not have damaged the health of the women concerned. At the time of diagnosis, harmless cancers cannot be identified as non-threatening, therefore women are offered invasive breast cancer treatment. This phenomenon of identifying (and treating) non-harmful cancers is called overdiagnosis. Overdiagnosis is morally problematic as it leads to overall patient harm rather than benefit. Further, breast cancer screening is offered in a context that exaggerates cancer risk and screening benefit, minimises risk of harm and impedes informed choice. These factors combine to create pathogenic vulnerability. That is, breast cancer screening exacerbates rather than reduces women’s vulnerability and undermines women’s agency. This paper provides an original way of conceptualising agency-supporting responses to the harms of breast cancer overdiagnosis through application of the concept of pathogenic vulnerability.

LanguageEnglish
Pages129–140
Number of pages12
JournalMedicine, Health Care and Philosophy
Volume22
Issue number1
Early online date20 Jul 2018
DOIs
Publication statusPublished - Mar 2019

Fingerprint

Ethics
Early Detection of Cancer
vulnerability
cancer
moral philosophy
Breast Neoplasms
Neoplasms
Patient Harm
Women's Health
Medical Overuse
Therapeutics

Bibliographical note

Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • Breast cancer
  • Ethics
  • Harm
  • Overdiagnosis
  • Pathogenic vulnerability
  • Screening
  • Vulnerability

Cite this

@article{91b2dd8a67214133a66fcb9caaca2008,
title = "Analysing the ethics of breast cancer overdiagnosis: a pathogenic vulnerability",
abstract = "Breast cancer screening aims to help women by early identification and treatment of cancers that might otherwise be life-threatening. However, breast cancer screening also leads to the detection of some cancers that, if left undetected and untreated, would not have damaged the health of the women concerned. At the time of diagnosis, harmless cancers cannot be identified as non-threatening, therefore women are offered invasive breast cancer treatment. This phenomenon of identifying (and treating) non-harmful cancers is called overdiagnosis. Overdiagnosis is morally problematic as it leads to overall patient harm rather than benefit. Further, breast cancer screening is offered in a context that exaggerates cancer risk and screening benefit, minimises risk of harm and impedes informed choice. These factors combine to create pathogenic vulnerability. That is, breast cancer screening exacerbates rather than reduces women’s vulnerability and undermines women’s agency. This paper provides an original way of conceptualising agency-supporting responses to the harms of breast cancer overdiagnosis through application of the concept of pathogenic vulnerability.",
keywords = "Breast cancer, Ethics, Harm, Overdiagnosis, Pathogenic vulnerability, Screening, Vulnerability",
author = "Rogers, {Wendy A.}",
note = "Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",
year = "2019",
month = "3",
doi = "10.1007/s11019-018-9852-z",
language = "English",
volume = "22",
pages = "129–140",
journal = "Medicine, Health Care and Philosophy",
issn = "1386-7423",
publisher = "Springer, Springer Nature",
number = "1",

}

Analysing the ethics of breast cancer overdiagnosis : a pathogenic vulnerability. / Rogers, Wendy A.

In: Medicine, Health Care and Philosophy, Vol. 22, No. 1, 03.2019, p. 129–140.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Analysing the ethics of breast cancer overdiagnosis

T2 - Medicine, Health Care and Philosophy

AU - Rogers, Wendy A.

N1 - Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2019/3

Y1 - 2019/3

N2 - Breast cancer screening aims to help women by early identification and treatment of cancers that might otherwise be life-threatening. However, breast cancer screening also leads to the detection of some cancers that, if left undetected and untreated, would not have damaged the health of the women concerned. At the time of diagnosis, harmless cancers cannot be identified as non-threatening, therefore women are offered invasive breast cancer treatment. This phenomenon of identifying (and treating) non-harmful cancers is called overdiagnosis. Overdiagnosis is morally problematic as it leads to overall patient harm rather than benefit. Further, breast cancer screening is offered in a context that exaggerates cancer risk and screening benefit, minimises risk of harm and impedes informed choice. These factors combine to create pathogenic vulnerability. That is, breast cancer screening exacerbates rather than reduces women’s vulnerability and undermines women’s agency. This paper provides an original way of conceptualising agency-supporting responses to the harms of breast cancer overdiagnosis through application of the concept of pathogenic vulnerability.

AB - Breast cancer screening aims to help women by early identification and treatment of cancers that might otherwise be life-threatening. However, breast cancer screening also leads to the detection of some cancers that, if left undetected and untreated, would not have damaged the health of the women concerned. At the time of diagnosis, harmless cancers cannot be identified as non-threatening, therefore women are offered invasive breast cancer treatment. This phenomenon of identifying (and treating) non-harmful cancers is called overdiagnosis. Overdiagnosis is morally problematic as it leads to overall patient harm rather than benefit. Further, breast cancer screening is offered in a context that exaggerates cancer risk and screening benefit, minimises risk of harm and impedes informed choice. These factors combine to create pathogenic vulnerability. That is, breast cancer screening exacerbates rather than reduces women’s vulnerability and undermines women’s agency. This paper provides an original way of conceptualising agency-supporting responses to the harms of breast cancer overdiagnosis through application of the concept of pathogenic vulnerability.

KW - Breast cancer

KW - Ethics

KW - Harm

KW - Overdiagnosis

KW - Pathogenic vulnerability

KW - Screening

KW - Vulnerability

UR - http://www.scopus.com/inward/record.url?scp=85050319650&partnerID=8YFLogxK

UR - http://purl.org/au-research/grants/arc/FT130100346

U2 - 10.1007/s11019-018-9852-z

DO - 10.1007/s11019-018-9852-z

M3 - Article

VL - 22

SP - 129

EP - 140

JO - Medicine, Health Care and Philosophy

JF - Medicine, Health Care and Philosophy

SN - 1386-7423

IS - 1

ER -